EU backs development of molecular Dx test for malaria

09/25/2013 | GenomeWeb Daily News (free registration)

Forsite Diagnostics will use a $728,438 grant from the European Commission to support the development of a molecular test to diagnose malaria quickly. The company is developing the blood-based assay for use in detecting Plasmodium falciparum or Plasmodium vivaxis parasites, which trigger malaria, to help doctors prescribe appropriate treatments immediately.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA